BMS310 Disease Processes (8)

The subject examines the processes of disease development in humans, together with the way that such processes are detected and monitored using laboratory tests. Emphasis will be placed on the role of common point-of-care tests which may be utilised.

Availability

Session 2 (60)
On Campus
Orange Campus

Continuing students should consult the SAL for current offering details: BMS310. Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System

HD/FL

Duration

One session

School

School of Dentistry and Medical Sciences

Incompatible Subjects

BMS511

Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to integrate and demonstrate knowledge from various biomedical science disciplines to gain an understanding of disease processes of the human body;
  • be able to demonstrate knowledge of the role of genetic factors in the development of both monogenic disorders and multifactorial human diseases;
  • know the range of clinical disorders commonly encountered by practising pharmacists;
  • be able to demonstrate knowledge of the need for drug therapy arising from an understanding of disease processes;
  • be able to describe and demonstrate knowledge of the biomedical rationale of routinely encountered laboratory and point-of-care tests;
  • be able to interpret results presented in routine pathology laboratory reports;
  • be able to perform point-of-care tests.

Syllabus

This subject will cover the following topics:
  • monogenic disorders, with special reference to cystic fibrosis and phenylketonuria;
  • gastrointestinal and hepatic disorders;
  • renal disorders, with special reference to fluid and electrolyte imbalances and renal transplantation;
  • cardiovascular disorders, with special reference to atherosclerosis, myocardial infarction and hyperlipidaemia;
  • respiratory disorders, with special reference to asthma;
  • neurological and psychiatric disorders, with special reference to Parkinsonism;
  • endocrine disorders, with special reference to diabetes mellitus and thyroid disorders;
  • reproductive disorders, with special reference to infertility;
  • haematological disorders, with special reference to disorders of blood fluidity;
  • malignant disorders, with special reference to leukaemias;
  • common point-of-care testing.

Indicative Assessment

The following table summarises the assessment tasks for the online offering of BMS310 in Session 2 2021. Please note this is a guide only. Assessment tasks are regularly updated and can also differ to suit the mode of study (online or on campus).

Item Number
Title
Value %
1
Minitest
10
2
Practical assessment
20
3
Mid session examination
35
4
Final exam
35

The information contained in the CSU Handbook was accurate at the date of publication: May 2022. The University reserves the right to vary the information at any time without notice.

Back